AMENDMENT NO. 3 RELATING TO SPONSORED RESEARCH AND LICENSE AGREEMENT BETWEEN CRITICAL THERAPEUTICS, INC. AND THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH DATED JANUARY 1, 2003 THIS AMENDMENT NO. 3 is made the 29th day of June, 2007. BETWEEN: (1)...Sponsored Research and License Agreement • August 9th, 2007 • Critical Therapeutics Inc • Pharmaceutical preparations • New York
RECITALSSponsored Research and License Agreement • March 23rd, 2000 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT INDEX 10.72 Sponsored Research and License Agreement dated as of May 1, 1995 between Progenitor, Inc. and Novo Nordisk* * Confidentiality requested for a portion of this Exhibit. Exhibit 10.72 Portions of this Exhibit have been omitted...Sponsored Research and License Agreement • October 3rd, 1995 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations
THE INFORMATION MARKED BY * AND [ ] HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED PORTIONS HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. AMENDED AND RESTATED SPONSORED RESEARCH AND LICENSE AGREEMENT THIS AGREEMENT,...Sponsored Research and License Agreement • March 14th, 1997 • Progenitor Inc • Biological products, (no disgnostic substances)
AMENDMENT NO. 4 relating to that certain SPONSORED RESEARCH AND LICENSE AGREEMENT between CORNERSTONE THERAPEUTICS INC., FORMERLY KNOWN AS CRITICAL THERAPEUTICS, INC., and THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH dated as of JANUARY 1, 2003Sponsored Research and License Agreement • November 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • New York
[***] Confidential portions of the exhibit have been omitted and filed separately with the Securities and Exchange Commission.
ANDSponsored Research and License Agreement • March 16th, 2007 • Critical Therapeutics Inc • Pharmaceutical preparations • New York
SPONSORED RESEARCH AND LICENSE AGREEMENTSponsored Research and License Agreement • January 10th, 2020 • ArTara Therapeutics, Inc. • Biological products, (no disgnostic substances) • Iowa
This Sponsored Research and License Agreement (this “Agreement”) is entered into on November 28, 2018 (the “Effective Date”), by and between ArTara, Inc. located at 1 Little West 12th Street, New York, NY 10014 (“ArTara”), and The University of Iowa, located at c/o Division of Sponsored Programs, 2 Gilmore Hall, Iowa City, IA 52242 (“University”). ArTara and University may individually be referred to herein as a “Party,” and collectively as “Parties.”
AMENDMENT NO. 6 RELATING TO SPONSORED RESEARCH AND LICENSE AGREEMENT BETWEEN CORNERSTONE THERAPEUTICS INC., FORMERLY KNOWN AS CRITICAL THERAPEUTICS, INC. AND THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH DATED JANUARY 1, 2003Sponsored Research and License Agreement • November 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • New York
AMENDMENT NO. 5 RELATING TO SPONSORED RESEARCH AND LICENSE AGREEMENT BETWEEN CORNERSTONE THERAPEUTICS INC., FORMERLY KNOWN AS CRITICAL THERAPEUTICS, INC., AND THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH DATED JANUARY 1, 2003Sponsored Research and License Agreement • November 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • New York
